Diagnosis and rational therapy of painful diabetic peripheral neuropathy (Interdisciplinary consensus of experts based on results the expert meeting on January 23, 2013, Moscow)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

EXPERT GROUP FOR PREPARATION OF RECOMMENDATIONS: chairpersons of expert group: academician of RAS Melnichenko G.A., academician of RAS Yachno N.N., academician of RAS Martynov A.I. responsible executors: professor G.R. Galstyan, professor E.G. Starostina, professor I.V. Gurjeva, MD A.Ju. Tokmakova, PhD M.V. Churjukanov. Members of the expert group: G.A. Melnichenko - deputy director of «Endocrinology scientific center» Federal State Budgetary Educational Institution, director of the Institute of clinical endocrinology, chairman of Moscow association of endocrinologists, vice president of Russian association of endocrinologists, academician of RAS, professor, M.D.; M.V. Shestakova - deputy director for scientific work of «Endocrinology scientific center» Federal State Budgetary Educational Institution, director of Institute of diabetes,academician of RAS, professor, MD; N.N. Yachno - professor of the Department of nervous diseases of general medicine faculty, director of scientific-educational clinical center of neurology of I.M. Sechenov First Moscow State Medical University, president of Russian pain studies society, academician of RAS, professor, MD; A.I. Martynov - professor of the Department of hospital therapy № 1 of general medicine faculty of A.I. Yevdokimov Moscow state university of medicine and dentistry, president of Russian scientific medical society of therapists, academician of RAS, professor, MD; G.R. Galstyan - head of the Department of diabetic foot, chief research worker of «Endocrinology scientific center» Federal State Budgetary Educational Institution, professor, MD; E.G. Starostina - professor of the Department of endocrinology of M.F. Vladimirsky Moscow Regional Scientific-Research Clinical Institute, professor, MD; II.V. Gurjeva - professor of the Department of endocrinology of general medicine faculty of of Additional post-graduate training state budgetary institution of Russian medical academy of continious professional education, head of medical social expertise and rehabilitation sector in case of endocrinous diseases of Federal State Budgetary Educational Institution Federal buro of medical social expertise of Ministry of Labour of Russia, professor, MD; M.L. Kukushkin - head of the laboratory of fundamental and applied pain problems of research institute of general pathology and pathophysiology of RAS, executive secretary of Russian society for pain studies, professor, MD; M.V. Chjurjukanov - associate professor of the Department of nervous diseases of general medicine faculty of I.M. Sechenov First Moscow State Medical University, PhD; I.A. Strokov - associate professor of the Department of nervous diseases of general medicine faculty of ГМ. Sechenov First Moscow State Medical University, PhD; AJu. Tokmakova - chief research worker of diabetic foot Department of «Endocrinological scientific center» Federal state budgetary educational institution, MD.

Full Text

Restricted Access

About the authors

- -

References

  1. Дедов И.И., Шестакова М.В., Викулова О.К. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета. Сахарный диабет. 2017;20 (1):13-41
  2. Дедов И.И., Шестакова М.В., Галстян Г.Р. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Клинические рекомендации / Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова (8-й выпуск). Сахарный диабет. 2017. Спец. выпуск 1: 2-111
  3. Болевые синдромы в неврологической практике. Под ред. А.М. Вейна, Москва, 2001.
  4. Hansson P., Fields H., Hill R., Marchettini P. (eds). Neuropathic Pain: Pathophysiology and Treatment, Progress in Pain Research and Management. Seattle, WA: IASP Press. 2001, 21, 151-167
  5. Rodica Pop-Busui, Andrew J.M. Boulton, Eva L. Feldman, Vera Bril, Roy Freeman, Rayaz A. Malik, Jay M. Sosenko, Dan Ziegler. Diabetic Neuropathy: A Position Statement by the American Diabetes Association Diabetes Care 2017;40:136-154 / DOI: 10.2337/ dc16-2042
  6. Albers J.W., Pop-Busui R. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep 2014; 14: 473; 3
  7. Dyck P.J., Albers J.W., Andersen H. et al. Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev 2011;27: 620-628
  8. Старостина Е.Г. Диабетическая нейропатия: некоторые вопросы дифференциальной диагностики и системной терапии болевого синдрома. РМЖ, Эндокринология; 2017: 22: 3-14.
  9. Biessels G.J., Bril V., Calcutt N.A. et al. Phenotyping animal models of diabetic neuropathy: a consensus statement of the Diabetic Neuropathy Study Group of the EASD (Neurodiab). J. Peripher Nerv Syst 2014;19:77-87.
  10. O'Brien P.D., Hinder L.M., Sakowski S.A., Feldman E.L. ER stress in diabetic peripheral neuropathy: a new therapeutic target. Antioxid Redox Signal 2014;21:621-633.
  11. Vincent A.M., Callaghan B.C., Smith A.L., Feldman E.L. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 2011;7:573-583; Zenker J., Ziegler D., Chrast R. Novel pathogenic pathways in diabetic neuropathy. TrendsNeurosci 2013;36:439-449.
  12. Malik R.A., Veves A., Tesfaye S. et al. Toronto Consensus Panel on Diabetic Neuropathy. Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy. Diabetes Metab Res Rev 2011;27:678-684.
  13. Baron R., Tolle T.R., Gockel U., Brosz M., Freynhagen R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. Pain 2009;146:34-40.
  14. Freeman R., Baron R., Bouhassira D., Cabrera J., Emir B. Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. Pain 2014; 1 55: 367-376
  15. Daousi C., MacFarlane I.A., Woodward A., Nurmikko T.J., Bundred P.E., Benbow S.J. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004; 21:976-982
  16. Davies M., Brophy S., Williams R., Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29:1 518-1522. 37
  17. Ziegler D., Rathmann W., Dickhaus T., Meisinger C., Mielck A. KORA Study Group. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med 2009; 10: 393-400.
  18. Vileikyte L., Leventhal H., Gonzalez J.S. et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care 2005;28:2378-2383.
  19. Vileikyte L., Rubin R.R., Leventhal H. Psycho-logical aspects of diabetic neuropathic foot com-plications: an overview. Diabetes Metab Res Rev 2004;20 (Suppl. 1):S13-S18
  20. Vinik E., Silva M.P., Vinik A.I. Measuring the relationship of quality of life and health status, including tumor burden, symptoms, and biochemical measures in patients with neuroendocrine tumors. Endocrinol Metab Clin North Am 2011;40:97-109.
  21. Boulton A.J., Malik R.A., Arezzo J.C., Sosenko J.M. Diabetic somatic neuropathies. Diabetes Care 2004; 27:1458-1486.
  22. Perkins B.A., Olaleye D., Zinman B., Bril V. Sim-ple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001; 24: 250-256.
  23. Tan L.S. The clinical use of the 10g mono-filament and its limitations: a review. Diabetes Res Clin Pract 2010; 90: 1-7.
  24. Boulton A.J., Armstrong D.G., Albert S.F. et al. American Diabetes Association; American Association of Clinical Endocrinologists. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008; 31:1679-1685.
  25. Archer A.G., Watkins P.J., Thomas P.K., Sharma A.K., Payan J. The natural history of acute painful neuropathy in diabetes mellitus. // J. NeurolNeurosurg Psychiatry. 1983;46:491-499.
  26. Boulton A.J., Vinik A.I., Arezzo J.C. et al. American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. // Diabetes Care. 2005; 28:956-962.
  27. Tesfaye S. еt al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments. // Diabetes Care. 2010; 33:2285-2293.
  28. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Christopher H. Gibbons Roy Freeman, Brain, Volume 138, Issue 1, 1 January 2015, Pages 43-52, https://doi.org/10.1093/brain/awu307, Published: 10 November 2014 Article history.
  29. Gibbons C.H., Freeman R. Treatment induced diabetic neuropathy- a reversible painful autonomic neuropathy Ann Neurol 2010, 67(4) ; 534-541.
  30. Diabetes Control and Complications Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. N. Engl J. Med 1993;329:977-986.
  31. Diabetes Control and Complications Research Group Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38:869-880.
  32. Linn T., Ortac K., Laube H., Federlin K. Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients. Metabolism 1996; 45:1 508-1513.
  33. Callaghan B.C., Cheng H.T., Stables C.L., Smith A.L., Feldman E.L. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012;1 1:521-534.
  34. Ismail-Beigi F., Craven T., Banerji M.A. et al. ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010; 376: 419-430.
  35. Ohkubo Y., Kishikawa H., Araki E. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
  36. ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010; 376: 419-430.
  37. Charles M., Ejskjaer N., Witte D.R., Borch- Johnsen K., Lauritzen T., Sandbaek A. Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION- Denmark study. Diabetes Care 2011;34:2244- 2249.
  38. Charles M., Fleischer J., Witte D.R. et al. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study. Diabetologia 2013; 56:101-108.
  39. Аng L., Jaiswal M., Martin C., Pop-Busui R. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep 2014;14:528.
  40. Pop-Busui R., Lu J., Brooks MM. et al. BARI 2D Study Group. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Re-vascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care 2013; 36:3208-3215.
  41. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
  42. Balducci S., Iacobellis G., Parisi L. et al. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications 2006; 20: 216-223.
  43. Singleton J.R., Marcus R.L., Jackson J.E., K. Lessard M., Graham T.E. Exercise increases cutaneous nerve density in diabetic patients without neuropathy. Ann.Clin.Transl.Neurol 2014;1:844-849.
  44. Carnethon M.R., Prineas R.J., Temprosa M., Zhang Z.M., Uwaifo G., Molitch M.E Diabetes Prevention Program Research Group. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care 2006; 29:914-919.
  45. Smith A.G., Russell J., Feldman E.L. et al. Lifestyle intervention for prediabetic neuropathy. Diabetes Care 2006;29:1294-1299.
  46. Приказ Минздрава России от 30.06.2015 № 386н «О внесении изменений в приложения к приказу Министерства здравоохранения Российской Федерации от 20 декабря 2012 г. № 1175н „Об утверждении порядка назначения и выписывания лекарственных препаратов, а также форм рецептурных бланков на лекарственные препараты, порядка оформления указанных бланков, их учета и хранения"»

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies